text
"[""\n1. 요약재무정보\n가. 요약연결재무정보\n\xa0 \xa0 \xa0 ( 단위 : 천원 )\n구분\n제 53 기 1분기\n제 52 기\n제 51 기\n연결재무상태표\n2023년 3월말\n2022년 12월말\n2021년 12월말\n\xa0[유동자산]\n38,857,064\n52,925,045\n76,863,062\n\xa0ㆍ현금및현금성자산\n4,747,708\n12,084,861\n9,186,408\n\xa0ㆍ단기금융상품\n50,000\n50,000\n91,943\n\xa0ㆍ매출채권\n18,929,839\n23,416,318\n20,859,343\n\xa0ㆍ금융자산\n4,647,639\n7,805,040\n-\n\xa0ㆍ기타자산\n7,945,995\n7,057,892\n4,405,358\n\xa0ㆍ매각예정비유동자산\n-\n-\n39,906,534\n\xa0ㆍ재고자산\n2,535,883\n2,510,934\n2,413,475\n\xa0[비유동자산]\n53,266,941\n53,581,480\n39,563,751\n\xa0ㆍ금융자산\n11,647,088\n11,987,234\n3,412,954\n\xa0ㆍ유형자산\n27,634,018\n26,819,937\n19,622,969\n\xa0ㆍ사용권자산\n2,549,294\n2,849,585\n1,930,936\n\xa0ㆍ무형자산\n9,355,701\n9,446,939\n11,204,427\n\xa0ㆍ장기매출채권\n86,432\n86,432\n133,463\n\xa0ㆍ기타자산\n1,994,408\n2,391,353\n3,259,002\n자 \xa0산 \xa0총 \xa0계\n92,124,005\n106,506,525\n116,426,813\n\xa0[유동부채]\n39,995,788\n53,957,876\n65,942,789\n\xa0[비유동부채]\n11,325,423\n11,293,282\n5,943,255\n부 채 총 계\n51,321,211\n65,251,158\n71,886,044\n\xa0[지배기업 소유지지분]\n40,802,794\n41,255,367\n31,144,703\n\xa0ㆍ자본금\n15,624,677\n15,624,677\n15,560,554\n\xa0ㆍ자본잉여금\n56,742,199\n56,742,199\n53,286,363\n\xa0ㆍ기타자본항목\n1,428,920\n1,428,920\n1,428,920\n\xa0ㆍ기타포괄손익누계액\n(4,014,047)\n(4,014,142)\n(4,007,401)\n\xa0ㆍ이익잉여금(결손금)\n(28,978,955)\n(28,526,287)\n(35,123,732)\n\xa0[비지배지분]\n-\n-\n13,396,065\n자 본 총 계\n40,802,794\n41,255,367\n44,540,769\n종속기업및 관계기업 투자주식의 평가방법\n원가법\n원가법\n지분법\n연결손익계산서\n23.01.01~03.31\n22.01.01~12.31\n'21.01.01~12.31\n\xa0매출액\n31,941,833\n137,224,812\n75,724,705\n\xa0영업손익\n210,232\n7,784,423\n(6,633,228)\n\xa0연결계속영업당기순이익\n(434,406)\n7,136,627\n(7,010,942)\nㆍ지배기업소유주지분손익\n(434,406)\n5,459,396\n(7,180,518)\nㆍ비지배기업소유주지분손익\n-\n1,677,231\n169,576\n\xa0연결중단영업당기순이익\n-\n-\n(911,372)\n\xa0당기순손익\n(434,406)\n7,136,627\n(7,922,314)\n\xa0주당순손익(원)\n(14)\n175\n(265)\n\xa0연결에포함된회사수\n1개\n1개\n1개\n※ 상기 요약 재무정보는 한국 채택국제회계기준(K-IFRS)에 따라 작성되었습니다.※ 2019년 1월 1일을 최초적용일로 하여 K-IFRS 제1116호를 최초 적용하였습니다.\n나. 연결재무제표의 연결에 포함된 회사\n종속기업명\n소유지분율\n소재지\n결산월\n업종\n셀론텍(주)\n100%\n한국\n12월\n바이오콜라겐 기반 치료재료 생산 및 판매\n다. 요약재무정보(별도)\n\xa0 \xa0 \xa0 ( 단위 : 천원 )\n구분\n제 53 기 1분기\n제 52 기\n제 51 기\n재무상태표\n2023년 3월말\n2022년 12월말\n2021년 12월말\n\xa0[유동자산]\n28,932,446\n40,309,304\n71,364,365\n\xa0ㆍ현금및현금성자산\n3,854,760\n8,319,019\n7,711,622\n\xa0ㆍ매출채권\n18,909,848\n22,957,160\n20,450,332\n\xa0ㆍ기타자산\n5,868,456\n8,883,358\n3,157,130\n\xa0ㆍ매각예정비유동자산\n-\n-\n39,906,534\n\xa0ㆍ재고자산\n299,382\n149,767\n138,747\n\xa0[비유동자산]\n47,178,884\n47,830,409\n28,233,309\n\xa0ㆍ금융자산\n11,646,988\n11,987,134\n3,412,954\n\xa0ㆍ종속기업및관계기업투자\n28,349,160\n28,349,160\n17,136,000\n\xa0ㆍ유형자산\n381,261\n374,120\n42,588\n\xa0ㆍ사용권자산\n1,550,043\n1,631,789\n265,543\n\xa0ㆍ무형자산\n4,335,170\n4,339,897\n5,734,757\n\xa0ㆍ장기매출채권\n86,432\n86,432\n133,463\n\xa0ㆍ기타자산\n829,830\n1,061,877\n1,508,004\n자 \xa0산 \xa0총 \xa0계\n76,111,330\n88,139,713\n99,597,674\n\xa0[유동부채]\n38,744,204\n49,685,108\n64,183,602\n\xa0[비유동부채]\n1,131,000\n1,185,573\n911,128\n부 채 총 계\n39,875,204\n50,870,681\n65,094,730\n\xa0ㆍ자본금\n15,624,677\n15,624,677\n15,560,554\n\xa0ㆍ자본잉여금\n50,693,232\n50,693,232\n51,132,267\n\xa0ㆍ기타포괄손익누계액\n(4,014,047)\n(4,014,142)\n(4,007,401)\n\xa0ㆍ이익잉여금(결손금)\n(26,067,736)\n(25,034,735)\n(28,182,476)\n자 본 총 계\n36,236,126\n37,269,032\n34,502,944\n종속기업 투자주식의 평가방법\n원가법\n원가법\n원가법\n관계기업 투자주식의 평가방법\n-\n-\n지분법\n손익계산서\n'23.01.01~03.31\n'22.01.01~12.31\n'21.01.01~12.31\n\xa0매출액\n28,960,025\n127,511,300\n80,226,517\n\xa0영업손익\n(371,786)\n1,989,721\n(4,012,277)\n\xa0당기순손익\n(1,033,000)\n2,045,845\n(4,457,200)\n\xa0주당순손익(원)\n(33)\n66\n(155)\n※ 상기 요약 재무정보는 한국 채택국제회계기준(K-IFRS)에 따라 작성되었습니다.※ 2019년 1월 1일을 최초적용일로 하여 K-IFRS 제1116호를 최초 적용하였습니다.\n""]"
